News & Perspective

Nov 01, 2019

Nov 01, 2019

ASP Scan (Weekly) for Nov 01, 2019

NICU quality improvement
Antibiotic data comparisons
Expert opinion on resistant TB
ICU antibiotic stewardship
Sepsis diagnostics funding
UTI antibiotics in nursing homes
GARDP antibiotic-development goal
CARB-X funding for novel drugs
UK vet antibiotic sales
XDR-TB drug maker chosen
Resistant Klebsiella in Germany
New pneumonia antibiotic OK'd

Apr 23, 2018

Apr 23, 2018

News Scan for Apr 23, 2018

HHS anthrax antitoxin buy
Ebola lab exposure
Measles vaccine gaps, death burden

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»